Pleural Malignant Mesothelioma

general

A malignant neoplasm that arises from mesothelial cells in the pleura and shows a diffuse growth pattern. It arises on the parietal and sometimes visceral pleura as multiple small nodules that later become confluent and invade the chest wall adipose tissue and muscle. Asbestos exposure is the main cause for the development of pleural malignant mesothelioma. It usually affects patients over sixty years of age. The latency period is long. Patients usually present with pleural effusion, dyspnea an

31

Centers

38

Active Trials

$1.8B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Recurrent Pleural Malignant Mesothelioma10

Top Centers for Pleural Malignant Mesothelioma(31)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.1
2
NCI Clinical
High-Volume Research Center
71.1
3
High-Volume Research Center
71.1
4
High-Volume Research Center
71.1
5
NCI Comprehensive
Active Research Program
50.2
6
NCI Comprehensive
Active Research Program
50.2
7
NCI Comprehensive
Active Research Program
50.2
8
NCI Comprehensive
Active Research Program
50.2
9
NCI Comprehensive
Active Research Program
50.2
10
NCI Comprehensive
Active Research Program
50.2
11
NCI Comprehensive
Active Research Program
50.2
12
NCI Comprehensive
Active Research Program
50.2
13
NCI Comprehensive
Active Research Program
50.2
1450.2
15
NCI Comprehensive
Active Research Program
50.2
16
NCI Comprehensive
Active Research Program
50.2
17
NCI Comprehensive
Active Research Program
50.2
18
NCI Comprehensive
Active Research Program
50.2
19
NCI Comprehensive
Active Research Program
50.2
20
NCI Clinical
Active Research Program
50.2
21
Active Research Program
50.2
22
NCI Comprehensive
Active Research Program
50.2
2350.2
24
Active Research Program
50.2
25
Active Research Program
50.2
26
Active Research Program
50.2
2730.9
28
NCI Comprehensive
30.9
29
NCI Comprehensive
30
NCI Comprehensive
31

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →